Complications of Diabetes Mellitus Clinical Trial
Official title:
The Effect of Reducing the Intraocular Pressure by Using Alphagan Drops and Macular Edema in Patients With Diabetic Macular Edema
The Investigators propose to examine the effect of lowering the intraocular pressure on macular edema in Participants diagnosed with diabetic macular edema. Our theory is based on the assumption that lower intraocular pressure means higher Ocular Perfusion pressure, which may cause an improvement in retinal perfusion and thus an improvement in retinal oxygenation and reduced edema
Ocular perfusion pressure (ocular perfusion pressure - OPP), considered the driving force of
ocular blood flow. Perfusion pressure is defined as the difference between the artery and
vein blood pressure. Because ocular venous pressure is the same or slightly higher than the
IOP (intra ocular pressure - IOP), it is common to estimate the OPP as the difference
between the arterial blood pressure of IOP. The OPP is critical for diffusion of oxygen,
nutrients and metabolic waste from retinal imaging, and decrease it may reduce blood flow to
the eye and lead to ischemia or hypoxia. the OPP is controlled by a complex system of
Autoregulation. Much has been written about the relationship between the OPP and glaucoma,
and agreed that OPP is a low risk factor for this disease.
Diabetic macular edema (DME) is the most common cause of vision loss in developed countries
the working-age.
Many studies were carried out in recent years in an attempt to better understand the
pathophysiology of Diabetic macular edema, and there is consensus in the scientific
literature that hypertension have a significant effect on Diabetic macular edema. this
relationship is much more complex than it seems at first glance. Paques and his team have
shown an inverse association between blood pressure to drop night and Diabetic macular
edema. LARSEN and his team have shown a similar trend.
Hayreh published an article from 2007, where he described the mechanism of improvement of
the Diabetic macular edema with discontinuation of hypertensive treatment and thereby
raising blood pressure. In this article, Hayreh describes hypoxia as a significant factor in
Diabetic macular edema, and demonstrated that treatment of hypoxia by increasing the OPP
brought good results in terms of macular thickness If so, it seems that there is not only a
link between levels of oxygenation of the retina to Diabetic macular edema, but that
improved oxygenation of the retina could lower the levels of macular edema in these
patients. If a way were found to improve retinal perfusion, this may lead to an improved
oxygenation and reduced edema. The Investigators propose to examine the relationship between
macular edema IOP in Participants with Diabetic macular edema, thinking that high IOP means
lower OPP, which means increased risk for developing macular edema in this Participants
group.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02335931 -
Characterization of the Charcot Foot
|
||
Completed |
NCT01926522 -
Technological Rehabilitation of Distal Sensorimotor Polyneuropathy in Diabetic Patients
|
N/A | |
Completed |
NCT02478190 -
ED Management of Severe Hyperglycemia: A Clinical Trial
|
N/A | |
Completed |
NCT03208309 -
Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin
|
Phase 2 | |
Completed |
NCT03530176 -
18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes
|
N/A | |
Recruiting |
NCT01439178 -
Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab
|
N/A | |
Completed |
NCT01821508 -
Clinical Study on Metabolic Surgery Compared to the Best Clinical Treatment in Patients With Type 2 Diabetes Mellitus
|
N/A |